Skip to main content

Long-term efficacy and safety of adalimumab in 4-12 year old patients with juvenile idiopathic arthritis

Access & Citations

  • 1706
    Article Accesses
  • 0
    Web of Science
  • 2
    CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.